Inogen to Announce Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026
Expansion Aligns with Innovation and Growth Strategy
Delivered seventh consecutive quarter of mid-single-digit revenue growth Reiterating full-year revenue guidance
Inogen, Inc. (Nasdaq: INGN ), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that it will report third quarter...
Inogen, Inc. (Nasdaq: INGN ), a leading medical technology company offering innovative respiratory products for use in the homecare setting, today announced the appointment of Naga...
Over the past year, the Medical Instruments industry has seen the transition of generative AI (genAI) from experimental to operational, reshaping diagnostics, patient monitoring and intervention workflows....
Delivered strong top-line results; raising full year 2025 revenue expectations
Inogen, Inc. (Nasdaq: INGN ), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that it will report second quarter...